1. Home
  2. ABAT vs BBOT Comparison

ABAT vs BBOT Comparison

Compare ABAT & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$2.72

Market Cap

517.0M

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$7.40

Market Cap

605.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
BBOT
Founded
2011
2016
Country
United States
United States
Employees
N/A
106
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
517.0M
605.6M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ABAT
BBOT
Price
$2.72
$7.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$6.00
$24.00
AVG Volume (30 Days)
8.0M
386.3K
Earning Date
05-15-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
43.14
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$7.00
52 Week High
$11.49
$14.87

Technical Indicators

Market Signals
Indicator
ABAT
BBOT
Relative Strength Index (RSI) 36.65 41.19
Support Level $2.63 $7.00
Resistance Level $3.67 $8.10
Average True Range (ATR) 0.33 0.50
MACD -0.09 0.00
Stochastic Oscillator 2.81 34.78

Price Performance

Historical Comparison
ABAT
BBOT

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: